Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by LifeStance Health Group in its filing.
Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.
The source filing: LifeStance Health Group’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338107
FAQ
- What is LifeStance Health Group's D&A?
- LifeStance Health Group (LFST) reported D&A of $14.25M in Q2 2026.
- How has LifeStance Health Group's D&A changed year-over-year?
- LifeStance Health Group's D&A increased by 1.7% year-over-year, from $14.01M to $14.25M.
- What is the long-term trend for LifeStance Health Group's D&A?
- Over 4 years (2021 to 2025), LifeStance Health Group's D&A has grown at a 0.3% compound annual growth rate (CAGR), from $54.14M to $54.75M.
- What does D&A mean?
- Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.
Ask your AI about LifeStance Health Group's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude